DrugRisk Update: Bayer Adds Gallbladder Claims to Yaz Settlements

The Drug Resource Center is the premiere source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz lawsuit
The company has spent nearly $1 billion to settle around 4,800 claims alleging blood clot injuries like deep vein thrombosis (DVT) or pulmonary embolism.

New York, NY (PRWEB) April 02, 2013

The birth control safety advocates at DrugRisk.com are announcing new information on the site for women who have taken the drugs Yaz or Yasmin. The manufacturer, Bayer, will now compensate certain patients who allege gallbladder injuries, in addition to the ongoing settlements for blood clots*.

The goal of DrugRisk is to improve patient safety by providing the latest warnings, recalls, studies and litigation news. Visitors can learn if others have experienced similar side effects and decide if they need legal help to join current litigation.

The resource center has learned that Bayer will designate $24 million to compensate patients who allege gallbladder injuries after taking Yaz or Yasmin*. While this could affect as many as 8,000 patients, payouts are only estimated at $2,000 to $3,000*.

Thousands more have filed a Yaz lawsuit alleging blood clot injuries, which were consolidated to a special federal Multi-District Litigation court in Illinois. The case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

Experts with the British Medical Journal and FDA have alerted patients that birth control pills containing drospirenone, like Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%**.

DrugRisk has obtained the latest financial reports from Bayer, which states the company has spent nearly $1 billion to settle around 4,800 claims alleging blood clot injuries like deep vein thrombosis (DVT) or pulmonary embolism***. The average amount paid to patients for these claims is over $208,000, much higher than for gallbladder injuries.

Lawyers are still helping those who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin learn their legal options for a Yaz settlement. Anyone affected is urged to contact the DrugRisk Resource Center or speak with a lawyer.

Due to the specialized nature of federal MDL drug injury cases, DrugRisk urges patients to seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects, a possible Yaz recall and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*newsandinsight.thomsonreuters.com/Legal/News/2013/03_-_March/Bayer_agrees_to_settle_Yasmin,_Yaz_gallbladder_lawsuits/
**British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints"
***Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013


Contact